AKT1 and melanoma: USP22 inhibition, PI3K inhibitor (GDC‐0941), Akt inhibitor (MK‐2206), and mTOR inhibitor (AZD‐8055) strongly inhibited melanoma invasion in melanoma cells (Figure 4F,G).